Nisa Investment Advisors
ATNM icon

Nisa Investment Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History

Nisa Investment Advisors’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$323 Hold
330
– – ﹤0.01% 3004
2026
Q1 		$328 Sell
330
-628
-66% -$747 ﹤0.01% 2917
2025
Q4 		$1.3K Hold
958
– – ﹤0.01% 2674
2025
Q3 		$1.53K Hold
958
– – ﹤0.01% 2669
2025
Q2 		$1.34K Sell
958
-402
-30% -$602 ﹤0.01% 2687
2025
Q1 		$2.19K Buy
1,360
+22
+2% +$28 ﹤0.01% 2447
2024
Q4 		$1.69K Buy
1,338
+1,106
+477% +$1.72K ﹤0.01% 2544
2024
Q3 		$436 Buy
232
+181
+355% +$715 ﹤0.01% 2741
2024
Q2 		$377 Buy
+51
New +$420 ﹤0.01% 2740
2023
Q4 		– Sell
-32
Closed -$189 – 2646
2023
Q3 		$189 Buy
+32
New +$213 ﹤0.01% 2675

Other funds holding ATNM

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Compass Financial Management Tampa, Florida $829M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Nisa Investment Advisors's ATNM Position: Q2 2026 in Review

Nisa Investment Advisors held its Actinium Pharmaceuticals (ATNM) position steady in Q2 2026 at 330 shares worth $323. The position accounts for ﹤0.01% of the portfolio, ranked #3004.

Nisa Investment Advisors first reported a position in ATNM in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.19K in Q1 2025. 47 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

  • Nisa Investment Advisors held 330 shares of Actinium Pharmaceuticals worth $323 as of Q2 2026.
  • Nisa Investment Advisors left its Actinium Pharmaceuticals share count unchanged in Q2 2026.
  • Actinium Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #3004 holding.
  • Nisa Investment Advisors first reported a position in Actinium Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • Nisa Investment Advisors's Actinium Pharmaceuticals position peaked at $2.19K in Q1 2025.
  • 47 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.